Skip to main content
Faeth Therapeutics

Director/Senior Director, Drug Safety & Pharmacovigilance

RemoteUnited States only
Published
Role
Research
Experience
Senior
Company size
Startup
$235k–$310k/yr
Check eligibility

Open to US only. Set where you work from to check your eligibility.

No BS summary

Experienced physician leader for Drug Safety & Pharmacovigilance in clinical-stage oncology. Requires pharmacovigilance/drug safety expertise, medical safety assessment, signal detection, and oversight of CROs/vendors. U.S.-based (Remote U.S.) candidates with 4+ years PV experience supporting Phase 2/3 oncology programs desired.

Core skills

PharmacovigilanceMedical safety assessment

Required skills

Drug safetySignal detectionRisk managementSafety surveillanceCRO oversightGlobal pharmacovigilance regulationsSafety reporting (aggregate safety reports, DSURs)Clinical study protocol safety sections

Optional skills

MD degreeBoard certification in Oncology or Hematology/Oncology or Internal MedicineExperience in large pharmaceutical companiesExperience in small-to-mid-sized biotechnology organizationsPrior experience as primary or lead medical safety physicianExperience supporting regulatory agency interactions related to drug safety

What you'll do

  • Serve as the medical lead for pharmacovigilance and drug safety activities across Faeth's clinical development programs.
  • Ensure appropriate oversight of safety processes and procedures, and vendor performance.
  • Provide medical review and oversight of safety data from ongoing clinical trials and lead safety signal detection, evaluation, interpretation, risk assessment activities.
  • Review and provide medical input in aggregate safety reports, DSURs, and other regulatory safety submissions.
  • Oversee safety surveillance activities conducted by external CROs, pharmacovigilance vendors, and consultants.
  • Own compliant execution of global safety activities with pharmacovigilance operations and regulatory team.
  • Lead development of safety sections of clinical study protocols, investigator brochures, informed consent forms, clinical study reports, and regulatory submissions.
  • Support interactions with regulatory authorities related to safety matters.
  • Lead Safety Management Team meetings and provide safety expertise to cross-functional development teams.
  • Collaborate with Clinical Development, Regulatory Affairs, Clinical Operations, Medical Writing, and Biostatistics to support program advancement.
  • Help evolve Faeth's safety team as programs progress through mid- and late-stage clinical development.

What they require

  • Minimum 4 years of pharmacovigilance and drug safety experience within the pharmaceutical or biotechnology industry.
  • Significant experience supporting oncology drug development programs.
  • Demonstrated expertise in medical safety assessment, signal detection, and risk management.
  • Experience overseeing CROs, pharmacovigilance vendors, and external consultants.
  • Working knowledge of global pharmacovigilance regulations and safety reporting requirements.
  • Experience supporting clinical development programs in Phase 2 and/or Phase 3 development.
  • Strong communication and cross-functional collaboration skills.
  • Ability to operate independently in a fast-paced, resource-efficient biotechnology environment.
  • Preferred: MD degree.
  • Preferred: Experience in both large pharmaceutical companies and small-to-mid-sized biotechnology organizations.
  • Preferred: Prior experience serving as the primary or lead medical safety physician for a development program.
  • Preferred: Experience supporting regulatory agency interactions related to drug safety.
  • Preferred: Board certification in Oncology, Hematology/Oncology, Internal Medicine, or a related specialty is preferred.

Benefits

  • Competitive salary and equity in a well-funded, clinical-stage biotech
  • 100% remote work and flexible schedule
  • Health, dental, and vision for you and your dependents
  • Flexible time off
  • Generous parental leave
  • Traditional and Roth 401k
  • Mission-oriented, remote-first culture

Faeth Therapeutics is a clinical-stage oncology company listed on Nasdaq that recently raised $200M in funding. With a strong scientific foundation and a founding team that includes the discoverer of our target pathway, we are advancing PIKTOR, a multi-node PI3K/AKT/mTOR inhibitor program, toward multiple near-term milestones.

BiotechStartup

Details

Visa sponsorshipNo
$235k–$310k/yr